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Abstract 
Asthma is a common respiratory disease that is characterized by chronic inﬂammation of the 
airways. In most asthmatic subjects, the immune response is driven by pro-inﬂammatory type 2 
cytokines (interleukin (IL)-4, IL-5 and IL-13) that correlate with hypersensitivity to 
environmental allergens and increased numbers of eosinophils in the airways and blood. In 2010, 
type 2 innate lymphoid cells (ILC2s) were identiﬁed as a novel type 2 cytokine-producing cell 
population. They were later found to promote allergen-related immune responses in the airway 
mucosa, where the alarmin cytokine IL-33 is an important driver.  
     Understanding the molecular mechanisms that cause excessive immune activation is an 
important area of asthma research. Gene regulatory microRNAs (miRNAs) are emerging as 
promising targets for modulation of type 2 immunity and play important roles in models of 
allergic asthma. However, miRNA expression in ILC2s and in the airways of human asthmatics 
is currently understudied. Using samples from asthmatic subjects and experimental mouse models 
of asthma we identiﬁed that miRNA-155 (miR-155) is critical for ILC2-mediated inﬂammation 
in mice (Paper I). Lung ILC2s increased miR-155 expression upon IL-33-mediated activation in 
vitro and miR-155 deficient ILC2s demonstrated decreased IL-13 production and lowered 
proliferative capacity to IL-33 administration in vivo. Importantly, this was accompanied by a 
severe reduction of airway eosinophils. We identiﬁed that miR-155 is diﬀerentially expressed in 
airways of subjects with allergic asthma compared to healthy controls (Paper II). Furthermore, 
induced sputum isolated from allergic asthmatics in and out of pollen season revealed that the 
level of miR-155 in sputum lymphocytes varied with the season. In Paper III, we identiﬁed a 
previously unrecognized role of ILC2s locally in murine bone marrow. We found that IL-5-
producing ILC2s contribute to the development and overproduction of eosinophils that promoted 
airway inﬂammation. Finally, we identiﬁed distinct diﬀerences in miRNA expression by 
examining miRNA proﬁles in airway macrophages isolated from bronchial lavage of asthmatic 
and healthy individuals (Paper IV). 
     Taken together, these studies demonstrate that miRNAs play important roles in airway 
immunity; miR-155 is necessary for the pro-inﬂammatory function of ILC2s, miR-155 expression 
is altered in airway lymphocytes from asthmatic subjects and a distinct miRNA signature is 
present in asthmatic airway macrophages. We also demonstrated that ILC2s have additional roles 
in allergic immunity and support eosinophilic airway inﬂammation by local reactions in the bone 
marrow. An increased understanding of the mechanisms that promote chronic type 2 inﬂammation 
in various tissues, and in speciﬁc cells, is essential for the development of improved prevention 
and therapy of the disease in the future. 
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